Vindhya Hindnavis, MD
Cardiovascular Disease (Cardiology) · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-San Jose · Kaiser Foundation Hospital-Santa Clara. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hindnavis’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A115662 · Current
Licensed to practise in California · since 2011 · expires 2028-09-30 · St Bartholomew'S and the Royal London School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-San JoseSan Jose, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.258, Oct 2024 – Sep 2025
- Kaiser Foundation Hospital-Santa ClaraSanta Clara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.38, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-San Jose
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.258 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.22 to 2.37) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.43 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 271 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 2,952 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.04 to 0.5) · 894 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 908 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.19 (0.67 to 5.72) · 176 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.34) · 61 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.23 (0.53 to 3.92) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.11 (0 to 17.58) · 68 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (0.67 to 9.03) · 63 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 51 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.43 (0 to 1.53) · 630 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 48 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.843 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.88 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.611 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 171 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 571 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 147.1 · 28 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 21 · 639 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 157 cases | None | Jul 2023 – Jun 2025 |
What patients said (1,294 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 61% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Clara
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 910 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.03 to 7.03) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.73 (3.81 to 19.64) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.3 to 9.32) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.72 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.049 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.598 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 589 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 828 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 107.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 642 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 181 cases | None | Jul 2023 – Jun 2025 |
What patients said (572 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
| Pacemaker insertion or repair | 1-10 | None |
Year by year
| 2022 | 12 | 12 | 66 | 1.87 | $11,389 | $2,273 |
| 2021 | 16 | 35 | 73 | 3.33 | $40,486 | $5,877 |
| 2018 | 14 | 23 | 67 | 2.37 | $28,443 | $4,613 |
| 2017 | 193 | 489 | 75 | 2.03 | $194,223 | $44,884 |
| 2016 | 387 | 1,504 | 74 | 1.91 | $828,671 | $173,843 |
| 2015 | 465 | 1,391 | 73 | 2.17 | $833,000 | $140,394 |
| 2014 | 446 | 1,413 | 73 | 1.93 | $686,190 | $123,231 |
| 2013 | 128 | 367 | 74 | 1.66 | $127,063 | $32,872 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2017: 9 services
| Return visit (30+ min) | 112 | $11,702 | $73 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 35 | $6,799 | $194 |
| Long return visit (40+ min) | 23 | $3,962 | $117 |
| New patient visit (45+ min) | 35 | $2,886 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,580 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,465 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,202 | $63 |
| Short return visit (20+ min) | 18 | $927 | $52 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 25 | $382 | $15 |
2016: 22 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 121 | $26,918 | $214 |
| Return visit (30+ min) | 154 | $26,439 | $93 |
| New patient visit (45+ min) | 119 | $16,286 | $137 |
| Long return visit (40+ min) | 70 | $13,212 | $127 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 20 | $11,879 | $457 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $10,500 | $167 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 38 | $9,600 | $253 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 76 | $8,664 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $7,234 | $88 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 37 | $6,709 | $160 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 25 | $3,029 | $87 |
| New patient visit (60+ min) | 17 | $2,800 | $165 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 41 | $2,751 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,670 | $99 |
| Short return visit (20+ min) | 28 | $1,985 | $62 |
| New patient visit (30+ min) | 18 | $1,541 | $86 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 19 | $1,526 | $73 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 74 | $1,151 | $16 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 19 | $440 | $23 |
| Ultrasonic guidance for blood vessel access | 26 | $322 | $12 |
| External ekg recording for more than 48 hours up to 21 days | 11 | $289 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 12 | $151 | $13 |
2015: 20 services
| Return visit (30+ min) | 187 | $26,626 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 71 | $15,333 | $199 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,644 | $164 |
| New patient visit (45+ min) | 69 | $9,657 | $140 |
| Long return visit (40+ min) | 55 | $9,022 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 80 | $8,627 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $6,646 | $87 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $6,540 | $467 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 23 | $5,837 | $254 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 96 | $5,210 | $54 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 23 | $4,947 | $215 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,925 | $112 |
| New patient visit (60+ min) | 22 | $3,665 | $167 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 18 | $2,816 | $148 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 32 | $2,706 | $80 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 50 | $966 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 62 | $960 | $15 |
| Short return visit (20+ min) | 11 | $720 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 50 | $629 | $13 |
| Ultrasonic guidance for blood vessel access | 15 | $225 | $12 |
2014: 15 services
| Return visit (30+ min) | 155 | $31,356 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 87 | $11,176 | $118 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 179 | $10,155 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $9,284 | $62 |
| New patient visit (30+ min) | 102 | $9,058 | $89 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $6,286 | $262 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 29 | $4,959 | $171 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $4,345 | $174 |
| Long return visit (40+ min) | 25 | $3,588 | $124 |
| New patient visit (45+ min) | 19 | $2,767 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,411 | $89 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 19 | $1,732 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 73 | $1,094 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 50 | $960 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 50 | $630 | $13 |
2013: 7 services
| New patient visit (30+ min) | 49 | $4,553 | $93 |
| Return visit (30+ min) | 33 | $3,979 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,892 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,303 | $60 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 56 | $3,038 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,701 | $169 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 32 | $561 | $17 |
Drugs they prescribed that Part D paid
$63,245
Pharmacies billed $63,245 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 309) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
247 generic and 62 brand-name prescriptions · $63,245 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entresto | 16 | $22,456 | $1,404 |
| Eliquis | 15 | $19,509 | $1,301 |
| Repatha Sureclick | 13 | $7,823 | $602 |
| Amiodarone | 15 | $722 | $48 |
| Metoprolol | 46 | $514 | $11 |
See all 11 drugs
| Entresto | 16 | $22,456 | $1,404 |
| Eliquis | 15 | $19,509 | $1,301 |
| Repatha Sureclick | 13 | $7,823 | $602 |
| Amiodarone | 15 | $722 | $48 |
| Metoprolol | 46 | $514 | $11 |
| Losartan | 31 | $392 | $13 |
| Clopidogrel | 14 | $252 | $18 |
| Metoprolol | 25 | $229 | $9 |
| Atorvastatin | 18 | $216 | $12 |
| Isosorbide Mononitrate Er | 15 | $164 | $11 |
| Amlodipine Besylate | 11 | $128 | $12 |
Year by year
| 2024 | 309 | 66 | 0% (0) | 20% | $63,245 |
| 2023 | 228 | 56 | 0% (0) | 15% | $28,554 |
| 2022 | 199 | 51 | 0% (0) | 18% | $21,633 |
| 2021 | 198 | 41 | 0% (0) | 16% | $15,586 |
| 2020 | 167 | 35 | 0% (0) | 12% | $5,549 |
| 2019 | 125 | 36 | 0% (0) | 17% | $4,809 |
| 2018 | 193 | 58 | 0% (0) | 30% | $14,873 |
| 2017 | 1,367 | 197 | 0% (0) | 22% | $68,987 |
| 2016 | 1,250 | 216 | 0% (0) | 19% | $41,014 |
| 2015 | 1,465 | 168 | 0% (0) | None | $39,923 |
| 2014 | 899 | 138 | 0% (0) | 17% | $29,204 |
| 2013 | 97 | 25 | 0% (0) | 23% | $4,495 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Eliquis | 12 | $14,058 | $1,172 |
| Metoprolol | 33 | $531 | $16 |
| Clopidogrel | 18 | $342 | $19 |
| Atorvastatin | 14 | $249 | $18 |
| Furosemide | 12 | $176 | $15 |
| Lisinopril | 14 | $170 | $12 |
| Metoprolol | 17 | $165 | $10 |
| Isosorbide Mononitrate Er | 11 | $125 | $11 |
2022: 5 drugs
| Metoprolol | 29 | $633 | $22 |
| Clopidogrel | 21 | $414 | $20 |
| Atorvastatin | 20 | $307 | $15 |
| Furosemide | 17 | $225 | $13 |
| Metoprolol | 20 | $203 | $10 |
2021: 6 drugs
| Metoprolol | 31 | $732 | $24 |
| Atorvastatin | 23 | $421 | $18 |
| Clopidogrel | 15 | $312 | $21 |
| Amlodipine Besylate | 13 | $172 | $13 |
| Furosemide | 13 | $152 | $12 |
| Lisinopril | 11 | $128 | $12 |
2020: 5 drugs
| Metoprolol | 28 | $549 | $20 |
| Clopidogrel | 17 | $415 | $24 |
| Atorvastatin | 13 | $218 | $17 |
| Lisinopril | 12 | $140 | $12 |
| Metoprolol | 12 | $118 | $10 |
2019: 4 drugs
| Atorvastatin | 15 | $416 | $28 |
| Metoprolol | 13 | $402 | $31 |
| Clopidogrel | 13 | $323 | $25 |
| Lisinopril | 12 | $140 | $12 |
2018: 7 drugs
| Clopidogrel | 17 | $501 | $29 |
| Atorvastatin | 17 | $497 | $29 |
| Metoprolol | 17 | $459 | $27 |
| Losartan | 14 | $186 | $13 |
| Carvedilol | 15 | $180 | $12 |
| Furosemide | 17 | $165 | $10 |
| Lisinopril | 11 | $130 | $12 |
2017: 26 drugs
| Xarelto | 57 | $28,112 | $493 |
| Eliquis | 25 | $11,238 | $450 |
| Metoprolol | 142 | $3,221 | $23 |
| Diltiazem 24hr Er | 31 | $2,215 | $71 |
| Atorvastatin | 139 | $2,054 | $15 |
| Clopidogrel | 129 | $1,652 | $13 |
| Carvedilol | 186 | $1,057 | $6 |
| Digoxin | 17 | $706 | $42 |
| Bisoprolol | 11 | $428 | $39 |
| Amlodipine Besylate | 85 | $402 | $5 |
| Lisinopril | 74 | $386 | $5 |
| Potassium Chloride | 13 | $376 | $29 |
| Warfarin | 28 | $327 | $12 |
| Hydralazine | 20 | $316 | $16 |
| Losartan | 46 | $295 | $6 |
| Furosemide | 69 | $292 | $4 |
| Enalapril Maleate | 11 | $224 | $20 |
| Simvastatin | 16 | $167 | $10 |
| Metoprolol | 39 | $165 | $4 |
| Pantoprazole | 20 | $163 | $8 |
| Klor-Con 10 | 12 | $154 | $13 |
| Omeprazole | 11 | $113 | $10 |
| Hydrochlorothiazide | 26 | $94 | $4 |
| Spironolactone | 14 | $81 | $6 |
| Atenolol | 13 | $64 | $5 |
| Ranitidine | 11 | $50 | $5 |
2016: 20 drugs
| Xarelto | 37 | $17,494 | $473 |
| Metoprolol | 159 | $3,447 | $22 |
| Atorvastatin | 107 | $1,365 | $13 |
| Clopidogrel | 114 | $1,294 | $11 |
| Carvedilol | 182 | $1,236 | $7 |
| Diltiazem 24hr Er | 13 | $863 | $66 |
| Furosemide | 92 | $525 | $6 |
| Lisinopril | 91 | $504 | $6 |
| Amlodipine Besylate | 74 | $423 | $6 |
| Potassium Chloride | 16 | $408 | $26 |
| Amiodarone | 11 | $352 | $32 |
| Metoprolol | 46 | $314 | $7 |
| Losartan | 38 | $304 | $8 |
| Warfarin | 36 | $300 | $8 |
| Hydralazine | 17 | $202 | $12 |
| Chlorthalidone | 15 | $197 | $13 |
| Simvastatin | 13 | $141 | $11 |
| Spironolactone | 15 | $105 | $7 |
| Pantoprazole | 14 | $80 | $6 |
| Hydrochlorothiazide | 23 | $79 | $3 |
2015: 23 drugs
| Xarelto | 33 | $12,663 | $384 |
| Metoprolol | 190 | $4,840 | $25 |
| Crestor | 11 | $3,587 | $326 |
| Carvedilol | 193 | $1,464 | $8 |
| Atorvastatin | 82 | $1,191 | $15 |
| Clopidogrel | 106 | $948 | $9 |
| Lisinopril | 140 | $787 | $6 |
| Pravastatin | 29 | $748 | $26 |
| Potassium Chloride | 28 | $708 | $25 |
| Furosemide | 133 | $705 | $5 |
| Amlodipine Besylate | 78 | $384 | $5 |
| Warfarin | 46 | $345 | $8 |
| Spironolactone | 44 | $316 | $7 |
| Isosorbide Mononitrate Er | 18 | $305 | $17 |
| Diltiazem 24hr Er | 11 | $298 | $27 |
| Hydralazine | 17 | $295 | $17 |
| Losartan | 44 | $242 | $6 |
| Simvastatin | 33 | $220 | $7 |
| Nitrostat | 11 | $175 | $16 |
| Amiodarone | 18 | $154 | $9 |
| Metoprolol | 32 | $140 | $4 |
| Hydrochlorothiazide | 30 | $97 | $3 |
| Omeprazole | 11 | $85 | $8 |
2014: 20 drugs
| Xarelto | 15 | $5,018 | $335 |
| Metoprolol | 108 | $3,143 | $29 |
| Bidil | 13 | $2,857 | $220 |
| Atorvastatin | 72 | $1,363 | $19 |
| Carvedilol | 95 | $957 | $10 |
| Clopidogrel | 56 | $743 | $13 |
| Pravastatin | 15 | $346 | $23 |
| Furosemide | 65 | $308 | $5 |
| Potassium Chloride | 11 | $303 | $28 |
| Lisinopril | 57 | $301 | $5 |
| Amlodipine Besylate | 41 | $297 | $7 |
| Hydralazine | 14 | $283 | $20 |
| Warfarin | 25 | $279 | $11 |
| Simvastatin | 48 | $266 | $6 |
| Losartan | 26 | $245 | $9 |
| Nitrostat | 15 | $244 | $16 |
| Isosorbide Mononitrate Er | 15 | $208 | $14 |
| Spironolactone | 22 | $155 | $7 |
| Metoprolol | 28 | $150 | $5 |
| Hydrochlorothiazide | 25 | $133 | $5 |
2013: 3 drugs
| Effient | 11 | $2,417 | $220 |
| Clopidogrel | 13 | $394 | $30 |
| Lisinopril | 13 | $45 | $3 |
Money from drug and device companies
$471 in 2025
| 2025 | 3 | 4 | None | $471 |
| 2024 | 1 | 1 | None | $100 |
| 2023 | 4 | 7 | None | $1,064 |
| 2022 | 1 | 1 | None | $151 |
| 2021 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $181 | 1 payment
|
| Abbott Laboratories | Ultreon | $149 | 1 payment
|
| Boston Scientific | General - Therapies | $140 | 2 payments
|
See all 4 published payments
| Boston Scientific | Meals · 2025-10-28 | General - Therapies | $56 |
| Shockwave Medical | Meals · 2025-10-24 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $181 |
| Abbott Laboratories | Meals · 2025-03-14 | Ultreon | $149 |
| Boston Scientific | Meals · 2025-02-22 | General - Therapies | $85 |
See earlier years (2024, 2023, 2022, 2021)
2024: $100
| Abbott Laboratories | Ultreon | $100 | 1 payment
|
2023: $1,064
| Boston Scientific | None | $358 | 3 payments
|
| Medtronic | Onyx Frontier | $254 | 2 payments
|
| Abbott Laboratories | Diamondback Coronary | $243 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $208 | 1 payment
|
2022: $151
| Boston Scientific | General - Therapies | $151 | 1 payment
|
2021: $20
| Shockwave Medical | Vascular Lithotripsy | $20 | 1 payment
|
Professional record
- NPI
- 1730353756
- Licence
- CA A115662, OH 57.012578, PA MD437751California A115662: Current · expires 2028-09-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Internal medicine (207R00000X)
- Mailing address
- 3687 Mt Diablo Blvd Ste 200, Lafayette, CA, 94549
- NPI first listed
- 2008-04-22
- NPI last updated
- 2021-12-17
- NPI record certified
- 2020-04-06
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.